Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Reduced turn-around time for Mycobacterium tuberculosis drug susceptibility testing with a proportional agar microplate assay V.A.T. Nguyen, H.Q. Nguyen,

Molecular evolution of Mycobacterium tuberculosis

Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm S.O. Simons, T. van der Laan,

Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan H. Ando, S. Mitarai, Y. Kondo, T. Suetake, J.-I. Sekiguchi,

R. Dumke, H. von Baum, P.C. Lück, E. Jacobs

High prevalence of azithromycin resistance to Treponema pallidum in geographically different areas in China X.-S. Chen, Y.-P. Yin, W.-H. Wei, H.-C. Wang,

Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review D. Papaventsis, N. Casali, I. Kontsevaya,

New epidemiology of Staphylococcus aureus infection in Asia

Gut bacterial microbiota and obesity

Salvage therapy for multidrug-resistant tuberculosis

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

Herpes zoster in non-hospitalized children

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.

J.-P. Van geertruyden Clinical Microbiology and Infection

A novel strategy based on genomics and specific PCR reveals how a multidrug-resistant Mycobacterium tuberculosis strain became prevalent in Equatorial.

Rapid and accurate detection of rifampin and isoniazid-resistant Mycobacterium tuberculosis using an oligonucleotide array W.-L. Huang, Z.-J. Hsu, T.C.

Whole genome analysis of Mycobacterium tuberculosis isolates from recurrent episodes of tuberculosis, Finland, 1995–2013 V. Korhonen, P.W. Smit, M. Haanperä,

GidB mutation as a phylogenetic marker for Q1 cluster Mycobacterium tuberculosis isolates and intermediate-level streptomycin resistance determinant in.

P. Nordmann, L. Poirel Clinical Microbiology and Infection

E. Cambau, M. Drancourt Clinical Microbiology and Infection

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Impact of immigration on tuberculosis in a low-incidence area of Italy: a molecular epidemiological approach C. Garzelli, N. Lari, B. Cuccu, E. Tortoli,

Genotypic characterization and historical perspective of Mycobacterium tuberculosis among older and younger Finns, 2008–2011 P.W. Smit, M. Haanperä,

Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan P.R. Hsueh, S.P. Tseng, L.J. Teng, S.W. Ho

Clinical Microbiology and Infection

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Vector control: a cornerstone in the malaria elimination campaign

Molecular mechanism of gentamicin resistance in Bartonella henselae

Distribution of rpoB mutations among multidrug-resistant Mycobacterium tuberculosis (MDRTB) strains from Thailand and development of a rapid method for.

Sofie Arens, Jan Verhaegen, Ludo Verbist

Characterization of Mycobacterium tuberculosis isolated from cancer patients with suspected tuberculosis infection in Egypt: identification, prevalence,

E.C. Böttger Clinical Microbiology and Infection

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience.

CMI editorial report 2011 Clinical Microbiology and Infection

S. Borrell, S. Gagneux Clinical Microbiology and Infection

Salvage therapy for multidrug-resistant tuberculosis

L. Zhang, Q. Meng, S. Chen, M. Zhang, B. Chen, B. Wu, G. Yan, X

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

Selection of rifampicin-resistant Mycobacterium tuberculosis does not occur in the presence of low concentrations of rifaximin Ornella Soro, Adelaide.

Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals H. von.

N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti

T.M. File Clinical Microbiology and Infection

Tuberculosis drug-resistance in Lisbon, Portugal: a 6-year overview

Update on antifungal resistance in Aspergillus and Candida

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

A.P. Underwood, J. Green Clinical Microbiology and Infection

Antimicrobial drug development – the past, the present, and the future

Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis C.C. Naidoo, M. Pillay Clinical.

C. Gagliotti, L. Nobilio, M.L. Moro

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting A. Kronenberg, S. Koenig, S. Droz,

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

Bloodstream infections due to Peptoniphilus spp.: report of 15 cases

Mixed infection with Beijing and non-Beijing strains in pulmonary tuberculosis in Taiwan: prevalence, risk factors, and dominant strain J.-Y. Wang, H.-L.

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Acquisition of second-line drug resistance and extensive drug resistance during recent transmission of Mycobacterium tuberculosis in rural China Y. Hu,

Joshua P. Metlay, Daniel E. Singer Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern Ukraine V.V. Nikolayevskyy, T.J. Brown, Y.I. Bazhora, A.A. Asmolov, Y.M. Balabanova, F.A. Drobniewski Clinical Microbiology and Infection Volume 13, Issue 2, Pages 129-138 (February 2007) DOI: 10.1111/j.1469-0691.2006.01583.x Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Prevalence of mutations associated with drug resistance and Beijing family strains among former prison inmates. MDR, multiple drug resistance. Clinical Microbiology and Infection 2007 13, 129-138DOI: (10.1111/j.1469-0691.2006.01583.x) Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Computer-generated image showing 73 variants of spoligopatterns of Mycobacterium tuberculosis isolates from Odessa and Nikolaev. SP1 to SP73 are variants of spoligopatterns; numbers in parentheses indicate the number of isolates sharing each spoligotype. Clinical Microbiology and Infection 2007 13, 129-138DOI: (10.1111/j.1469-0691.2006.01583.x) Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions